Hyaluronic Acid Fillers Don’t Dissolve (Not the Way You Think)
- “Dissolvable” is a simplification. HA fillers often persist and can migrate; imaging has identified filler years after injection.
- Biology first: hyaluronidase isn’t chronically secreted at injection sites; crosslinking alters HA breakdown.
- Early immune activity can dissolve some material, but complete, uniform clearance is unlikely in many placements.
- A better path: restore native architecture via controlled turnover, inflammation control, and lipid/matrix support.
The problem with assumptions
Skincare “facts” spread quickly; verification rarely keeps up. A common claim is that hyaluronic acid (HA) fillers fully dissolve on a predictable timetable. Some material does clear. But complete dissolution in all patients, placements, and timeframes is not supported by biology — or by imaging.
How HA is actually broken down
HA is degraded by hyaluronidases — enzymes that cleave HA polymers. To dissolve filler, the body must supply hyaluronidase to the depot consistently over time. It usually doesn’t; chronic secretion would jeopardize native HA in skin, muscle, cartilage, and other matrices.
- Hyaluronidase secretion tends to be transient, tied to early post-injection immune activity.
- Locations with limited perfusion or encapsulation are less accessible to hyaluronidase-bearing cells.
- Persistent depots may remain quiescent yet present, sometimes with migration over time.
How long dissolution lasts
Biology-guided view: Most endogenous dissolution happens in the first 2–4 weeks post-injection, when immune traffic and hyaluronidase are highest. As the response resolves, enzymatic pressure wanes. If hyaluronidase persisted indefinitely, adjacent native tissues would be at risk — biology avoids that outcome.
MRI & ultrasound evidence
Clinical imaging has identified HA fillers well beyond typical marketing windows:
- MRI/US detection of filler in patients up to 2, 6, 10+ years after injection; periocular regions are frequent sites of persistence and migration.
- Prospective series report limited volume reduction over 12 months in some cohorts.

Overview discussion on long-term filler visibility and migration: video discussion.
Cosmetic vs natural HA (and why half-life matters)
Endogenous HA is dynamic: approximate half-life is minutes in blood, <24 hours in skin, and weeks in cartilage. Commercial HA fillers are crosslinked hydrogels engineered for stability; crosslinking and particle architecture alter susceptibility to hyaluronidase and prolong residence time. This helps explain multi-year detectability.

There’s another way
If your face feels slightly “off” years later, you’re not imagining it. Filler may not vanish; it can move, reshape planes, and subtly alter architecture. OUMERE’s approach is to rebuild what your skin is already designed to do — without trauma, dependence, or opaque gels.
- Restore controlled turnover with No.9 (PHA) so surface reflects light evenly and texture refines.
- Protect & calm with UV-R to reduce inflammatory collagen loss and TEWL triggers.
- Rebuild lipid architecture with Serum Bioluminelle for hydration retention and resilience.
- Cleanse without alkalizing using Oil Dissolution Theory to preserve microbiome and barrier lipids.
- Night repair signaling with Advancement II for matrix organization and visible smoothness.

No.9 — Controlled Exfoliation (PHA)
Orderly turnover without irritation; refines texture and clarity.

UV-R — Anti-inflammatory Cellular Repair
Calms reactivity; protects collagen from immune-mediated breakdown.

Serum Bioluminelle — Lipid Biophysics
Locks in hydration; restores comfort and light scatter.

Oil Dissolution Theory — Non-stripping Cleanse
Preserves barrier lipids and microbiome; no alkaline stress.
Further Reading & Research
References
- Becker, M., et al. (2015). HA filler in HIV-associated facial lipoatrophy: MRI distribution/morphology. Dermatology, 230(4), 367–374.
- Di Girolamo, M., et al. (2015). MRI in evaluation of facial dermal fillers. European Radiology, 25(5), 1431–1442.
- Leng, Y., et al. (2019). HA, CD44, RHAMM regulate myoblast behavior. Matrix Biology, 78, 236–254.
- Lin, X., et al. (2020). Bone ECM in formation/regeneration. Frontiers in Pharmacology, 11, 757.
- Master, M. (2021). Filler longevity/localization: MRI evidence. Plast Reconstr Surg, 147(1), 50e–53e.
- Papakonstantinou, E., Roth, M., Karakiulakis, G. (2012). HA: key molecule in skin aging. Dermato-Endocrinology, 4(3), 253–258.
- Rivera Starr, C., Engleberg, N.C. (2006). Role of hyaluronidase in GAS spread. Infect Immun, 74(1), 40–48.
- Tal, S., et al. (2016). MRI in detecting facial cosmetic injectables. Head & Face Medicine, 12(1), 1–7.
Bottom line: HA fillers are not reliably temporary. Biology and imaging both suggest persistence and migration. OUMERE’s system supports visible youth by reinforcing the skin’s own design — no gels required.
Editor’s Lab Note
A note from the OUMERE Laboratory
Hyaluronic acid is essential to the extracellular matrix; indiscriminate, chronic hyaluronidase exposure would endanger native tissues. Crosslinked injectable HA resists rapid clearance, explaining long-term detectability. The OUMERE method favors homeostasis over implants: controlled turnover (No.9), anti-inflammatory protection (UV-R), lipid biophysics (Serum Bioluminelle), and non-stripping cleansing (Oil Dissolution Theory). For advanced night support, see Advancement II.
Cosmetic and educational content. Not medical advice.